About this episode

Nick interviews Pedro Gonzalez de Cosio about Pharmakon's innovative approach to financing in the life sciences sector.

This week Nick talks to Pedro Gonzalez de Cosio Pedro Gonzalez de Cosio is the Chief Executive Officer and co-founder of Pharmakon. Before co-founding the firm, he spent 14 years in structured finance, holding senior roles at Deutsche Bank and JPMorgan in New York. There, he specialized in structuring complex collateralized financing and derivative transactions for U.S. and international clients, including several years focused on the biotechnology and pharmaceutical sectors. Nick and Pedro discuss Pharmakon’s approach to providing non-dilutive debt financing to life sciences companies, how the firm supports biotech businesses through key growth stages, and what differentiates its investment strategy. They also explore successful investments, the role of non-dilutive capital in funding innovation and acquisitions, the competitive landscape for biotech financing, differences between U.S. and European capital markets, and emerging healthcare trends, including orphan diseases, oncology, GLP-1 therapies, AI in drug discovery, and the future of cancer treatment. Pedro's Book Choices The Godfather by Mario Puzo The Emperor of All Maladies by Siddhartha Mukherjee Pedro's Music Choices…

More episodes of A Different Perspective

• A Different Perspective: Chris McVey on the Once-in-a-Generation Opportunity in UK Small & Mid-Cap Stocks · June 30, 2026 · 44 min
• A Different Perspective with Alk Brand, CEO of Wynnstay Group PLC · June 16, 2026 · 40 min

Explore listener stats, chart rankings, contacts and more on the A Different Perspective podcast page.